Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0

Impact assessment of [¹⁸F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative and volume-based PET metrics

Baseline FDG PET/CT–Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer

Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck

Unilateral absent brown adipose tissue activity and diaphragmatic paralysis allowing precise delineation of lymphoma-associated nerve damage.